Meeting
2018 Gastrointestinal Cancers Symposium
The expression of versican and its role in pancreatic neuroendocrine tumors.
Authors
Zhao Sun
Peking Union Medical College Hospital, Beijing, China
Zhao Sun , Heli Gao , Junjie Gu , Yuejuan Cheng , Yuanjia Chen , Chunmei Bai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 254)
DOI
10.1200/JCO.2018.36.4_suppl.254
Abstract #
254
Poster Bd #
C7
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
A new immunohistochemistry prognostic score (IPS) for recurrence and survival in pancreatic neuroendocrine tumors (PanNET).
First Author: Antonio Viudez
Poster
2023 ASCO Annual Meeting
ERBB2 mRNA expression to distinguish HER2-low/neg breast cancer prognosis.
First Author: Yueping Liu
Poster
2023 ASCO Annual Meeting
Differential benefit of capecitabine-based chemotherapy among TNBC subtypes in the context of the CBCSG010 study.
First Author: Junjie Li
Poster
2022 ASCO Genitourinary Cancers Symposium
Analysis of disease-free survival in CheckMate 274 by PD-L1 combined positive score and tumor proportion score.
First Author: Matt D. Galsky